The role of previously untreated patient studies in understanding the development of FVIII inhibitors.
about
Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa).A close insight to factor VIII inhibitor in the congenital hemophilia A.Non-genetic risk factors in haemophilia A inhibitor management - the danger theory and the use of animal models.Analyses of the FranceCoag cohort support immunogenicity differences among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol.
P2860
The role of previously untreated patient studies in understanding the development of FVIII inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The role of previously untreat ...... velopment of FVIII inhibitors.
@en
type
label
The role of previously untreat ...... velopment of FVIII inhibitors.
@en
prefLabel
The role of previously untreat ...... velopment of FVIII inhibitors.
@en
P2093
P2860
P356
P1433
P1476
The role of previously untreat ...... velopment of FVIII inhibitors.
@en
P2093
P2860
P356
10.1111/HAE.12790
P577
2015-08-27T00:00:00Z